Interact to see
Advertisement
Advertisement
CPLSX vs NLSCX
CPLSX vs NLSCX Comparison
Open Charts CPLSX vs NLSCX
Calamos Phineus Long/Short A
Price$17.77
Change-$0.05 (-0.28%)
VolumeN/A
Net Assets1.14B
Neuberger Berman Long Short C
Price$18.62
Change+$0.03 (+0.16%)
VolumeN/A
Net Assets7.57B
CPLSX vs NLSCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
CPLSX vs. NLSCX commentary
Aug 15, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPLSX is a Buy and NLSCX is a Buy.
FUNDAMENTALS
Fundamentals
NLSCX has more cash in the bank: 7.57B vs. CPLSX (1.14B). CPLSX pays higher dividends than NLSCX: CPLSX (3.35) vs NLSCX (0.00). CPLSX was incepted earlier than NLSCX: CPLSX (9 years) vs NLSCX (14 years). CPLSX (2.44) and NLSCX (2.43) have similar cost to investors . CPLSX is a more actively managed with annual turnover of: 342.00 vs. NLSCX (48.00). NLSCX has a lower initial minimum investment than CPLSX: NLSCX (1000) vs CPLSX (2500). CPLSX annual gain was more profitable for investors over the last year : 11.24 vs. NLSCX (8.71). CPLSX return over 5 years is better than : 60.28 vs. NLSCX (19.24).
| CPLSX | NLSCX | CPLSX / NLSCX | |
| Total Expense Ratio | 2.44 | 2.43 | 100% |
| Annual Report Gross Expense Ratio | 2.44 | 2.43 | 100% |
| Fund Existence | 9 years | 14 years | - |
| Gain YTD | 11.411 | 5.088 | 224% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 2500 | 1000 | 250% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.14B | 7.57B | 15% |
| Annual Yield % from dividends | 3.35 | 0.00 | - |
| Returns for 1 year | 11.24 | 8.71 | 129% |
| Returns for 3 years | 18.96 | 11.86 | 160% |
| Returns for 5 years | 60.28 | 19.24 | 313% |
| Returns for 10 years | N/A | 37.91 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LICYX | 18.13 | N/A | N/A |
| Lord Abbett International Equity I | |||
| ETAHX | 36.65 | N/A | N/A |
| Eventide Healthcare & Life Sciences A | |||
| VSPMX | 436.74 | N/A | N/A |
| Vanguard S&P Mid-Cap 400 Index I | |||
| VDVIX | 14.60 | N/A | N/A |
| Vanguard Developed Markets Index Inv | |||
| CLFFX | 21.73 | -0.27 | -1.23% |
| Clifford Capital Partners Investor | |||